Stay updated on Nivolumab Ramucirumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.

Latest updates to the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page
- Check7 days agoChange DetectedThe page now indicates recruitment is not ongoing and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label is reformatted and a Revision: v3.6.0 tag is applied.SummaryDifference0.5%

- Check14 days agoChange DetectedRevision label on the page updated from v3.5.4 to v3.5.5. This signals a new version of the ClinicalTrials.gov record was published.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page's study record dates were updated to add recent timestamps (2026-05-22, 2026-12, 2026-05-20, 2026-05) and remove older ones (2026-01-14, 2026-04, 2026-01-13, 2026-01). This reflects updates to the study timeline in the record.SummaryDifference0.3%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a newer revision of the page content. This change reflects an underlying update to the page as metadata rather than a modification to the visible study details.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision tag updated from v3.5.2 to v3.5.3, signaling a new build of the ClinicalTrials.gov page. No study-related content changes are indicated by this revision.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Ramucirumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ramucirumab Combo in NSCLC Clinical Trial page.